These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27042273)

  • 1. Association of chemokine ligand 5/chemokine receptor 5 gene promoter polymorphisms with diabetic microvascular complications: A meta-analysis.
    Zhang Z; Zhang X; Dong J; Gao W; Liu F; Zhao J; Wu X; Guan X; Liu J; Liao L
    J Diabetes Investig; 2016 Mar; 7(2):212-8. PubMed ID: 27042273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects.
    Nakajima K; Tanaka Y; Nomiyama T; Ogihara T; Ikeda F; Kanno R; Iwashita N; Sakai K; Watada H; Onuma T; Kawamori R
    Diabetes Care; 2003 Mar; 26(3):892-8. PubMed ID: 12610055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotactic cytokine receptor 5 (CCR5) gene promoter polymorphism (59029A/G) is associated with diabetic nephropathy in Japanese patients with type 2 diabetes: a 10-year longitudinal study.
    Mokubo A; Tanaka Y; Nakajima K; Watada H; Hirose T; Kawasumi M; Sakai K; Kanazawa A; Maeda S; Hosokawa K; Atsumi Y; Matsuoka K; Kawamori R
    Diabetes Res Clin Pract; 2006 Jul; 73(1):89-94. PubMed ID: 16442182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects.
    Ying H; Wang J; Gao X
    Tumour Biol; 2014 Jun; 35(6):5895-904. PubMed ID: 24687549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between chemokine receptor 5 (CCR5) delta32 gene variant and atherosclerosis: a meta-analysis of 13 studies.
    Zhang Z; Liu J; Wang H; Wu H; Wu X; Dong J; Liao L
    Int J Clin Exp Med; 2015; 8(1):658-65. PubMed ID: 25785041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer.
    Weng CJ; Chien MH; Lin CW; Chung TT; Zavras AI; Tsai CM; Chen MK; Yang SF
    Oral Oncol; 2010 Oct; 46(10):767-72. PubMed ID: 20729133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians.
    Prasad P; Tiwari AK; Kumar KM; Ammini AC; Gupta A; Gupta R; Thelma BK
    BMC Med Genet; 2007 Apr; 8():20. PubMed ID: 17428349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation.
    Kim DH; Jung HD; Lee NY; Sohn SK
    Transplantation; 2007 Oct; 84(7):917-25. PubMed ID: 17984846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CCL5 and CCR5 gene polymorphisms with periodontitis in Taiwanese.
    Shih YS; Fu E; Fu MM; Lin FG; Chiu HC; Shen EC; Chiang CY
    J Periodontol; 2014 Nov; 85(11):1596-602. PubMed ID: 25119558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy.
    Pettigrew KA; McKnight AJ; Patterson CC; Kilner J; Sadlier DM; Maxwell AP
    J Hum Genet; 2010 Apr; 55(4):248-51. PubMed ID: 20203694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.
    Tsai HT; Yang SF; Chen DR; Chan SE
    Med Oncol; 2012 Dec; 29(4):2771-9. PubMed ID: 22374185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea.
    Ahn SH; Kim DY; Chang HY; Hong SP; Shin JS; Kim YS; Kim H; Kim JK; Paik YH; Lee KS; Chon CY; Moon YM; Han KH
    J Med Virol; 2006 Dec; 78(12):1564-71. PubMed ID: 17063508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between CC motif chemokine ligand 5 (CCL5) polymorphisms and asthma risk: an updated meta-analysis.
    Huang H; Nie W; Zang Y; Chen J; Xiu Q
    J Investig Allergol Clin Immunol; 2015; 25(1):26-33. PubMed ID: 25898691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect.
    Mlynarski WM; Placha GP; Wolkow PP; Bochenski JP; Warram JH; Krolewski AS
    Diabetes; 2005 Nov; 54(11):3331-5. PubMed ID: 16249462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.
    Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M
    Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
    Hellier S; Frodsham AJ; Hennig BJ; Klenerman P; Knapp S; Ramaley P; Satsangi J; Wright M; Zhang L; Thomas HC; Thursz M; Hill AV
    Hepatology; 2003 Dec; 38(6):1468-76. PubMed ID: 14647058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the promoter of the CCL5 gene (CCL5G-403A) in a cohort of North Indian children with Kawasaki disease. A preliminary study.
    Chaudhuri K; Singh Ahluwalia T; Singh S; Binepal G; Khullar M
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S126-30. PubMed ID: 21418786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
    Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Ning Y; Cremolini C; Antoniotti C; Borelli B; Mashima T; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Lonardi S; Yamaguchi T; Falcone A; Loupakis F; Lenz HJ
    Clin Colorectal Cancer; 2018 Jun; 17(2):e395-e414. PubMed ID: 29606345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.
    Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S; Bahari G; Mashhadi MA; Taheri M
    Cancer Biomark; 2014; 14(5):343-51. PubMed ID: 25171476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.